iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021.

Create Account

Dark

chart

exchange

Check out our Dark Pool Levels

iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021.

GlobeNewswire Inc | Aug 2, 2021 04:05PM EDT

August 02, 2021

NASHUA, N.H., Aug. 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021.

Fireside Chat DetailsDate: August 10, 2021Time: 10:00am Eastern Time

About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:Media Inquiries:Jessica Burns, iCAD +1-201-423-4492jburns@icadmed.com

Investor Relations:Jeremy Feffer, LifeSci Advisors+ 1-212-915-2568jeremy@lifesciadvisors.com